Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Apollo Endosurgery is raising $20,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Todd Newton played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Apollo Endosurgery

Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal conditions. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs.

To learn more about Apollo Endosurgery, visit http://www.apolloendo.com/

Contact:
Todd Newton, Chief Executive Officer
512-279-5100
todd.newton@apolloendo.com
https://www.linkedin.com/in/todd-newton-941099185/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved